SCHEMBL508677

SCHEMBL508677

Nc1n[c]cc(O)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5567049 0.74
SCHEMBL11423232 0.70
SCHEMBL2867903 0.70
SCHEMBL508305 0.70
SCHEMBL8633137 0.70
SCHEMBL11669067 0.65
SCHEMBL8921275 0.65
SCHEMBL95816 0.64
SCHEMBL9172126 0.61 NPC1 (0.37)
SCHEMBL29546940 0.61 NPC1 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0233015-B1 1,4-Dihydropyridines WYETH JOHN & BROTHER LTD (GB) 1995-10-18 EP claimed
EP-0174131-A2 Dihydropyridines, processes and intermediates for their production, and pharmaceutical formulations containing them FISONS plc (GB) 1986-03-12 EP claimed
EP-1762567-B1 Pyrazole derivatives for treating HIV PFIZER LTD (GB) 2012-05-02 EP disclosed
US-20120029192-A1 Pyrazole Derivatives PFIZER INC 2012-02-02 US disclosed
US-8063044-B2 Pyrazole derivatives PFIZER INC. (US) 2011-11-22 US disclosed
US-20090215712-A1 PYRAZOLE DERIVATIVES PFIZER INC 2009-08-27 US disclosed
US-7435728-B2 Pyrazole derivatives PFIZER INC (US) 2008-10-14 US disclosed
EP-1377556-B1 PYRAZOLE DERIVATIVES FOR TREATING HIV PFIZER LTD (GB) 2007-04-04 EP disclosed
EP-1762567-A1 Pyrazole derivatives for treating HIV Pfizer Limited (GB) 2007-03-14 EP disclosed
US-7138403-B2 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity JANSSEN PHARMACEUTICA N.V. (BE) 2006-11-21 US disclosed
US-7109228-B2 Pyrazole derivatives AGOURON PHARMACEUTICALS, INC. (US) 2006-09-19 US disclosed
EP-0562833-B1 Anti-ulcer pyridyloxy derivatives, their preparation and uses SANKYO CO (JP) 1996-05-08 EP disclosed
EP-0233015-B1 1,4-Dihydropyridines WYETH JOHN & BROTHER LTD (GB) 1995-10-18 EP disclosed
CN-1081437-A Antiulcer pyridine oxygen derivative, their preparation method and purposes SANKYO CO (JP) 1994-02-02 CN disclosed
EP-0562833-A1 Anti-ulcer pyridyloxy derivatives, their preparation and uses SANKYO COMPANY LIMITED (JP) 1993-09-29 EP disclosed
EP-0174131-A2 Dihydropyridines, processes and intermediates for their production, and pharmaceutical formulations containing them FISONS plc (GB) 1986-03-12 EP disclosed
US-4202900-A Derivatives of penam-3-carboxylic acid and a pharmaceutical composition containing the same CIBA-GEIGY CORPORATION (US) 1980-05-13 US disclosed
US-4202900-A Derivatives of penam-3-carboxylic acid and a pharmaceutical composition containing the same CIBA-GEIGY CORPORATION (US) 1980-05-13 US disclosed
US-4015000-A 6-Acylamino-penam-3-carboxylic and 7-acylamino-3-cephem-4-carboxylic acids CIBA-GEIGY CORPORATION (US) 1977-03-29 US disclosed
US-4015000-A 6-Acylamino-penam-3-carboxylic and 7-acylamino-3-cephem-4-carboxylic acids CIBA-GEIGY CORPORATION (US) 1977-03-29 US disclosed